An historical example of selective publication with contemporary implications: lead smelter workers and cancer

References

• Patterson CC. Contaminated and natural lead environments of man. Arch Environ Health. 1965;11:344–60.
   Google Scholar
• Warren C. Brush with death: a social history of lead poisoning. Baltimore, (MD): Johns Hopkins University Press; 2000. p. 210–9.
   Google Scholar
• Committee on Biologic Effects of Atmospheric Pollutants. Lead: airborne lead in perspective. Washington (DC): National Academy of Sciences; 1972. p. 13.
   Google Scholar
• Markowitz G, Rosner D. Deceit and Denial: the deadly politics of industrial pollution. Berkeley, (CA): University of CA Press; 2002.
   Google Scholar
• Branin v. ASARCO, 93-CV-5132, Accession # 021-04-0102, Box 1–9, Location # 3050865, settlement papers obtained at Seattle Federal Records Center, hereafter referred to as Branin v. ASARCO.
   Google Scholar
• Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008;299(15):1800–12.
   PubMed Web of Science ®Google Scholar
• Tong EK, Glantz SA. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation. 2007;116(16):1845–54.
   PubMed Web of Science ®Google Scholar
• Lee YO, Glantz SA. Menthol: putting the pieces together. Tobacco Control. 2011;20(Suppl 2):ii1–7.
   PubMed Web of Science ®Google Scholar
• Fu H, Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med. 1995;52:73–81.
   PubMed Web of Science ®Google Scholar
• US Department of Labor, Occupational Safety and Health Administration. Lead [Internet] [cited 2011 Jul 7]. Available from: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table = standards&p_id = 10030
   Google Scholar
• Technology Planning and Management Corporation. Final Report on Carcinogens, Background Document for Lead and Lead Compounds. Research Triangle Park (NC): Department of Health and Human Services (US), Public Health Service, National Toxicology Program; 2003 May. Contract No.: NO1-ES-85421. p. 33.
   Google Scholar
• CDC. Human lead absorption — Texas. MMWR Morb Mortal Wkly Rep. 1973;22:405–7.
   Google Scholar
• Landrigan PJ, Baker EL, Feldman RG, Cox DH, Eden KV, Orenstein WA, et al.. Increased lead absorption with anemia and slowed nerve conduction in children near a lead smelter. J Pediatr. 1976;89(6):904–10.
   PubMed Web of Science ®Google Scholar
• US Geological Survey. Lead Statistics-1900–2009 [Internet] [cited 2011 May 26]. Available from: http://minerals.usgs.gov/ds/2005/140/lead.pdf
   Google Scholar
• Varner M. ASARCO Incorporated: the Department of Environmental Sciences: ASARCO; (Undated), Branin v. ASARCO.
   Google Scholar
• Church MA. Smoke Farming: smelting and agricultural reform in Utah, 1900–1945. Utah Hist Q. 2004;72(Summer):196–218.
   Google Scholar
• Wirth JD. Smelter Smoke in North America: the politics of transborder pollution. Lawrence (KS): University Press of Kansas; 2000.
   Google Scholar
• Pinto SS. (ASARCO Medical Department, Tacoma, WA). Personal and Confidential Letter to: Mr Douglas Soutar (ASARCO New York, NY). 1965 Oct 5, Branin v. ASARCO.
   Google Scholar
• Proceedings of Symposium on Environmental Lead Contamination; 1965 Dec 13–15; Washington (DC), USA. Washington (DC): Department of Health, Education, and Welfare (US), Public Health Service; 1966.
   Google Scholar
• Nelson KW (ASARCO Department of Hygiene, Salt Lake City, UT). Personal and Confidential Letter to: Mr. Douglas Soutar (ASARCO, New York, NY). 1966 July 18. Branin v. ASARCO.
   Google Scholar
• Jecklin L. Lead dust and lung cancer (Ger.) Schweiz Med Wschr. 1956;86:891–2. Cited in Technology Planning and Management Corporation. Final Report on Carcinogens, Background Document for Lead and Lead Compounds. Research Triangle Park (NC): Department of Health and Human Services (US), Public Health Service, National Toxicology Program; 2003 May. Contract No.: NO1-ES-85421, p. 41.
   Google Scholar
• Dingwall-Fordyce I, Lane RE. A follow-up study of lead workers. Br J Ind Med. 1963;20:313–5.
   PubMedGoogle Scholar
• National Institute for Occupational Safety and Health (US). Criteria for a Recommended Standard: occupational exposure to inorganic lead revised criteria — 1978. Washington (DC): Department of Health and Human Services (US); 1978. (NIOSH Publication No. 78–158).
   Google Scholar
• Cooper WC, Gaffey WR. Mortality of lead workers. J Occup Med. 1975;17(2):100–7.
   PubMedGoogle Scholar
• Cooper WC, Wong O, Kheifets L. Mortality among employees of lead battery plants and lead-producing plants, 1947–1980. Scand J Work Environ Health. 1985;11:331–45.
   PubMed Web of Science ®Google Scholar
• Wong O, Harris F. Cancer mortality study of employees at lead battery plants and lead smelters, 1947–1995. Am J Ind Med. 2000;38:255–70.
   PubMed Web of Science ®Google Scholar
• Selevan SG, Landrigan PJ, Stern FB, Jones JH. Mortality of lead smelter workers. Am J Epidemiol. 1985;122(4):673–83.
   PubMed Web of Science ®Google Scholar
• Steenland K, Selevan S, Landrigan P. The mortality of lead smelter workers: an update. Am J Public Health. 1992;82(12):1641–4.
   PubMed Web of Science ®Google Scholar
• Lundstrom NG, Nordberg G, Englyst V, Gerhardsson L, Hagmar L, Jin T, et al.. Cumulative lead exposure in relation to mortality and lung cancer morbidity in a cohort of primary smelter workers. Scand J Work Environ Health. 1997;23(1):24–30.
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Agency for Research on Cancer. IARC Monographs 87 Inorganic and Organic Lead Compounds. Lyon (France); 2006.
   Google Scholar
• Steenland K, Boffetta P. Lead and cancer in humans: where are we now? Am J Ind Med. 2000;38:295–9.
   PubMed Web of Science ®Google Scholar
• Silbergeld EK, Waalkes M, Rice JM. Lead as a carcinogen: experimental evidence and mechanisms of action. Am J Ind Med. 2000;38:316–23.
   PubMed Web of Science ®Google Scholar
• Rousseau MC, Straif K, Siemiatycki J. IARC Carcinogen Update. Environ Health Perspect. 2005;113(9):A580–1.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Report on carcinogens. 12th ed. Research Triangle Park, NC: Department of Health and Human Services (US), Public Health Service, National Toxicology Program; 2011. p. 251.
   Google Scholar
• Integrated Risk Information System, Lead and Lead Compounds (inorganic) (CASRN 7439-92-1) [Internet] [cited 2011 Jul 6]. Available from: http://www.epa.gov/iris/subst/0277.htm
   Google Scholar
• CDC. Adult blood lead epidemiology and surveillance — United States, 2008–2009. MMWR Morb Mortal Wkly Rep. 2011;60(25):841–5.
   PubMedGoogle Scholar
• Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124.
   PubMed Web of Science ®Google Scholar
• Egilman D, Ardolino E. The pharmaceutical industry, disease industry: a prescription for illness and death. In: , Wiist W H, editor. The bottom line or public health. New York: Oxford University Press; 2010. p. 193–224.
   Google Scholar
• Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252–60.
   PubMed Web of Science ®Google Scholar
• Davis D. The secret history of the war on cancer. New York: Basic Books; 2007.
   Google Scholar
• Brandt A. The cigarette century: rise, fall and deadly persistence of the product that defined America. New York: Basic Books; 2007.
   Google Scholar
• Hardy H, Egilman D. Corruption of occupational medical literature: the asbestos example. Am J Ind Med. 1991;20(1):127–9.
   PubMed Web of Science ®Google Scholar
• McCulloch J. Saving the asbestos industry, 1960–2006. Public Health Rep. 2006;121(5):609–14.
   PubMed Web of Science ®Google Scholar
• de Angelis C, Drazen J, Frizelle F, Haug C, Hoey J, Horton R, et al.. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004;351:1250–1.
   PubMed Web of Science ®Google Scholar
• US Public Law 110–85 (Food and Drug Administration Amendments Act of 2007 or FDAAA), Title VIII, Section 801.
   Google Scholar
• Wagner W, Michaels D. Equal treatment for regulatory science: extending the controls governing the quality of public research to private research. Am J Law Med. 2004;30:119–54.
   PubMed Web of Science ®Google Scholar
• Michaels D. Foreword: Sarbanes-Oxley for Science. Law Contemp Probl. 2006;69(3):1–19.
   Google Scholar